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Abstract A number of cyclometalated palladium(II) complexes [PdCl(pyC6H4)(L)] 
containing amino-pyridine or acetylamino-pyridine co-ligands (L) have been prepared from 
the reaction of [Pd(pyC6H4)(µ-Cl)]2 with two equivalents of these ligands. Crystal structures 
of four examples have been carried out, each showing a distorted square planer geometry 
around palladium with the amino- or acetylamino-pyridine ligand being coordinated via 
nitrogen atom and lying almost perpendicular to the square-plane. Similarly, 
[PdCl(pyC6H4)(κ1-dppmO)] and [PdCl(pyC6H4)(κ1-dppeO)] result from reactions of 
[Pd(C6H4py)(µ-Cl)]2  with Ph2PCH2P(O)PPh2 (dppmO) and Ph2PCH2CH2P(O)PPh2 (dppeO) 
respectively. Here the phosphine ligand is attached via only phosphorus, however, removal of 
the chloride upon addition of AgNO3 lead to the formation of [Pd(pyC6H4)(κ2-dppmO)][NO3] 
and [Pd(pyC6H4)(κ2-dppeO)][NO3] in which the ligands are believed to bind in a chelate 
fashion.  
Keywords: palladium, cyclometalated, crystal structure, 2-phenylpyridine, synthesis 
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1. Introduction 
Organometallic palladium complexes containing cyclometalated ligands have attracted 
widespread interest for applications as anti-cancer treatments [1-5] and in catalysis [6-11], 
together with their novel physical properties [12-17]. The development of this chemistry 
stems in part from the ready availability of starting materials. Thus in 1968 reaction of 2-
phenylpyridine with Na2[PdCl4] was shown to afford a simple, high yielding route to the 
chloro-bridged dimer [Pd(pyC6H4)(µ-Cl)]2 (1) [18]. This has been used as a precursor 
towards the synthesis of a wide range of monomeric complexes of the type [PdCl(pyC6H4)L] 
(Scheme 1). For example, addition of carbon monoxide affords [PdCl(pyC6H4)(CO)] [13] and 
PPh3 affords [PdCl(pyC6H4)(PPh3)] [19]. With monoanionic chelate ligands such as 
dithiocarbamates the chloride displacement is also facile affording neutral complexes 
[Pd(pyC6H4)(S2CNR2)] [20,21], while with chelating neutral ligands (L2) such as 
diphosphines and diamines, salts of the form [Pd(pyC6H4)(L2)][Cl] result [13,22]. 
 
Palladium complexes containing heterocyclic nitrogen-containing ligands, such as derivatives 
of pyridine, quinoline, pyrazole, and 1,10-phenanthroline, especially the trans analogues with 
non-planar amine ligands, have been found to overcome multifactorial cisplatin resistance in 
human ovarian cell lines [23,24]. Given this, we were somewhat surprised to note that 
palladium complexes of the type [PdCl(pyC6H4)L] containing simple pyridine-derived 
ligands were relatively rare. Thus, López and co-workers have reported the synthesis of 
[PdCl(pyC6H4)(py)] upon reaction of 1 with pyridine in acetone, together with various related 
amine complexes [PdCl(pyC6H4)(NH3)] and [PdCl(pyC6H4)(NH2R)] (R = Pri, But) [25]. 
Pazderski and co-workers also reported the synthesis of [PdCl(pyC6H4)(py)] together with a 
series of pyridine derivatives including the 2,4,6-trimethylpyridine complex which was 
crystallographically characterised [26]. Herein we report the related synthesis and 
characterisation of a series of amino- and acetylamino-pyridine complexes [PdCl(pyC6H4)L]. 
The aim of our work was to see if these ligands would act as mono- or bidentate ligands. In 
all cases the former is seen and this is confirmed by the crystal structures of four examples. In 
developing this idea further we also report the synthesis of diphosphine monoxide complexes, 
[PdCl(pyC6H4){κ1-Ph2P(CH2)nPPh2(O)}] (n = 1,2), for which spectroscopic data strongly 
suggest a monodentate coordination through phosphorus. However, addition of silver nitrate 
to these complexes result in precipitation of AgCl and the formation of salts in which the 
ligand acts as a P,O-chelate. 
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Scheme 1. 
 
2. Results and discussion 
2.1 Synthesis and characterisation of [PdCl(pyC6H4)L] - Treatment of [Pd(pyC6H4)(µ-Cl)]2 
(1) with two equivalents of 2-aminopyridine in ethanol afforded after work-up the yellow 
mononuclear complex [PdCl(pyC6H4)(2-apy)] (2) in 78% yield. Similar reactions with 2-
amino-3-methylpyridine (2-ampy), 2-aminopyrimidine (2-apym) and 2-ethylpyridine (2-etpy) 
also afforded related complexes 3-5 as yellow solids in 60-80% yields (Scheme 2). 
Spectroscopic and analytical data were in full accord with the proposed formulations. The 1H 
NMR spectra (in d6-dmso) were particularly informative with each showing a complex series 
of signals in the aromatic region of the spectrum over some 3 ppm. For example for 2, eleven 
separate signals were observed between δ 9.43-6.23 consistent with the inequivalence of all 
aromatic protons, while the amine protons were observed as a singlet at δ 5.76.     
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Scheme 2.  
 
In order to confirm the above formulations, crystal structures were carried out on 2-4 the 
results of which are summarised in Figures 1-2 and Table 1. Each consists of discrete 
monomeric molecule with distorted square planer geometry around palladium. The metal 
atom is ligated to one nitrogen and ortho-carbon of phenyl-pyridine ligand, one chloride and 
the nitrogen of the introduced ligand. In all cases a regioselective N-trans-N bonding mode is 
observed. The Pd-C and Pd-N bond distances are in good agreement with the previously 
reported palladium compounds [13,22,26-28]. The two cyclic ligands are approximately at 
right angles to one another (see Figure 2b), dihedral angles between the two planes being 
84.82º, 70.06º and 81.17º for 2-4 respectively. The Pd-Cl bond lengths are fall in the range 
2.3697(11)-2.4251(7) Å. 
 
Reaction of 1 with two equivalents of 2,6-diaminopyridine affords [PdCl(pyC6H4)(2,6-dapy)] 
(6) as a yellow solid in 88% yield. Characterisation was made on the basis of analytical and 
spectroscopic data. The 1H NMR spectrum is as expected for coordination through the 
pyridine nitrogen atom, a singlet at δ 5.44 being assigned to the four NH2 protons. Likewise 
reactions with N-(2-pyridyl)acetamide (2-acpy) and N-(2-pyrimidyl)acetamide (2-acpym) 
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afford [PdCl(pyC6H4)(2-acpy)] (7) and [PdCl(pyC6H4)(2-acpym)] (8) in ca. 60-70% yields. 
Addition of 2-aminobenzothiazole (2-abzt) and benzothiazolacetamide (2-bzta) also afford 
similar compounds [PdCl(pyC6H4)(2-abzt)] (9) and [PdCl(pyC6H4)(2-bzta)] (10) respectively 
(Scheme 2). To confirm the formation of 9 a crystal structure was carried out the results of 
which are summarised in Figure 3 and Table 1. Crystallographically the system is more 
complex with three independent molecules in the asymmetric unit. However there are only 
small differences between them and only one is shown. The molecular structure is very 
similar to those of 2-4 and the dihedral angle between the planes of the two cyclic ligands is 
86.09º in the molecule shown. 
 
2.2 Synthesis and characterisation of diphosphine-oxide complexes [PdCl(pyC6H4){κ1-
Ph2P(CH2)nP(O)Ph2}] and [Pd(pyC6H4){κ2-Ph2P(CH2)nP(O)Ph2}][NO3] (n = 1,2) -  
Complexes containing hemi-labile diphosphine monoxide ligands have been extensively 
described with some being found to be efficient catalysts for a range of processes [29-34]. 
Following the successful synthesis of the pyridyl and amino-pyridyl complexes described we 
attempted the preparation of Ph2PCH2P(O)Ph2 (dppmO) and Ph2PCH2CH2P(O)Ph2 (dppeO) 
complexes. Heating a mixture of 1 and two equivalents of dppmO in dichloromethane for 2 h 
resulted in the slow formation of a yellow solution which after removal of solids, cooling to 
room temperature and slow evaporation of the solvent afforded [PdCl(pyC6H4)(κ1-dppmO)] 
(11) in 82% yield as a yellow solid. A similar reaction with dppeO gave [PdCl(pyC6H4)(κ1-
dppeO)] (12) in 68% yield. Unfortunately we have been unable to obtain single crystals of 
either suitable for a structural study and thus assignment is based on analytical and 
spectroscopic data. Both show two resonances in the 31P{1H} NMR spectrum appearing at ca. 
32.6 and 28.3 ppm in 11 and 46.4 and 36.2 ppm for 12. In 12 the two signals are relatively 
sharp and appear as doublets (JPP 52 Hz), but in 11 the signal at 32.6 ppm is very broad and 
no couplings can be extracted. This suggests that there is a fluxional process taking place on 
the NMR timescale, possibly rotation about the Pd-P bond. Room temperature 1H NMR 
spectra of both display a series of sharp signals, the methylene protons of the dppm(O) ligand 
appearing as a triplet a δ 4.39 (J 12.0 Hz), while for 12 a multiplet at δ 2.59 integrating to 
four protons.  These data are consistent with the formation of complexes in which the 
diphosphine is bound in a monodentate fashion through phosphorus (Scheme 3). Addition of 
AgNO3 to CH2Cl2 solutions of 11-12 resulted in a significant darkening of the solutions, 
elimination of AgCl and formation of 13–14 respectively. The 31P{1H} chemical shifts of 
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these cationic complexes are displaced downfield with regard to free ligand corresponding to 
phosphorus-coordinated complexes, as reported previously for related complexes [35-38], 
and being attributed to binding of the electronegative oxygen to the metal centre. Thus in 13 a 
pair of doublets are observed at 54.3 and 28.2 ppm (JPP 53 Hz), while 14 is characterised by 
two slightly broad singlets at 46.4 and 36.2 ppm. The methylene protons in 14 are now 
observed as a complex multiplet centred at δ 2.79, while in 13 a triplet is observed at δ 4.59 
(JPH 8.0 Hz). While we cannot fully ascertain which regioisomer is generated in each 
instance, in all cases the regioselectivity is high. We favour the isomers shown in Scheme 3 
in which the phosphorus lies trans to the nitrogen of the 2-pyridylphenyl ligand. 
 
 
 
Scheme 3 
 
As far as we are aware diphosphine-oxide complexes of this type have not previously been 
reported. However, the proposed six-membered chelate in 14 is likely to be very similar to 
that recently reported for [Pd(C6H4py){κ2-Ph2P(o-C6H4)C(O)H}][OTf], prepared in a related 
two-step procedure upon reaction of ortho-(diphenylphosphino)benzaldehyde with 
[Pd(pyC6H4)(µ-Cl)]2 (1) which initially affords [PdCl(C6H4py){κ1-Ph2P(o-C6H4)C(O)H}] and 
then converts to the chelate upon addition of silver triflate [39].  
3. Experimental  
3.1 General methods and materials 
All reactions were carried out in air using standard bench reagents. NMR spectra were 
recorded at the Institut für Chemie, Martin-Luther-Universität, Halle-Wittenberg, Germany, 
or University of Zaragoza, Spain on Varian Unity 500 and Gemini 200 spectrometers, 
respectively. IR spectra were recorded on a Shimadzu FT-IR 8400 spectrophotometer using 
KBr discs in the range 400-4000 cm-1. Elemental analyses were carried out at University 
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College London, Martin-Luther-Universität, Halle-Wittenberg, Germany and University of 
Zaragoza, Spain. Melting points were measured on Gallenkamp melting point apparatus and 
were uncorrected. Na2[PdCl4], 2-phenylpyridine, 2-aminobenzothiazole (2-abzt), 2-
aminopyridine (2-apy), 2-aminopyrimidine (2-apym), 2-amino-3-methylpyridine (2-ampy), 
2,6-diaminopyridine (2,6-dapy) and 2-ethylpyridine (2-etpy) were purchased and used as 
supplied. Compounds [Pd(pyC6H4)(µ-Cl)]2 (1) [40], N-(2-pyridyl-3-methyl) acetamide (2-
acmpy) [41], N-(2-pyridyl)acetamide (2-acpy) [42], benzothiazolacetamide (2-bzta) [43] 
were prepared by literature methods.  
3.2 Synthesis of [PdCl(pyC6H4)(2-apy)] (2) - A solution of 2-apy (0.050 g, 0.1337 mmol) in 
acetone (5ml) was added to a yellow suspension of 1 (0.0395 g, 0.0668 mmol) in acetone (10 
ml). The resulting yellow solution was stirred for 2 h, filtered and slow evaporation of the 
solvent at room temperature gave yellow prismatic crystals (0.041 g, 78 %). Anal. Calc. for 
C16H14ClN3Pd, C, 49.1, H, 3.6, N, 10.7. Found: C, 49.0, H, 3.8, N, 10.8 %. IR (KBr) 3047- 
3299s, 3157-3068m, 1625vs, 1600s, 406m cm-1. 1H NMR (dmso-d6) δ 9.43 (dd, 1H, J 3.9, 
0.8), 8.40 (dd, 1H, J 5.7, 0.8), 7.82 (ddd, 1H, J 8.0, 7.7, 1.5), 7.66 (d, 1H, J 7.9), 7.50 (ddd, 
1H, J 8.0,  7.7, 1.5), 7.45 (dd, 1H, J 7.5, 1.5), 7.17 (ddd, 1H, J 6.4, 5.6, 1.2), 7.09 (ddd, 1H, J 
7.6, 7.5, 1.2), 6.91(ddd, 1H, J 7.4, 7.2, 1.2), 6.74-6.68 (m, 2H), 6.23 (dd, 1H, J 7.7, 1.2), 5.76 
(s, 2H, NH2).  Mp 252-254 oC. 
3.3 Synthesis of [PdCl(pyC6H4)(2-ampy)] (3) - A solution of 2-ampy (0.200 g, 1.337 mmol) 
in CH2Cl2 (5 ml) and five drops of NEt3 was added to a yellow suspension of 1 (0.395 g, 
0.668 mmol) in CH2Cl2 (10 ml). The resulting yellow solution was stirred a room temperature 
for 3h, filtered and left to evaporate at room temperature. The yellow cubic crystals formed 
were filtered off and dried under vacuum (0.040 g, 75 %). Anal. Calc. for C17H16ClN3Pd, C, 
50.5, H, 3.9, N, 10.4. Found: C, 50.4, H, 3.8, N, 10.4. IR (KBr) 3417-3305s, 3170-3062w, 
2918w, 2852w, 1618s, 1598s, 406m cm-1. 1H NMR (dmso-d6) δ 9.46 (d, 1H, J 7.9), 8.32 (d, 
1H, J 7.9), 7.81 (ddd, 1H, J 8.0, 7.9, 4.0), 7.66 (d, 1H, J 7.9), 7.46 (d, 1H, 
 
J 7.9), 7.40 (d, 1H, 
J 3.9), 7.18 (dd, 1H, J 5.9, 4.0), 7.08 (dd, 1H, 5.9, 4.0), 6.93 (dd, 1H, J 8.0, 7.9), 6.70 (dd, 1H, 
J 6.0, 5.9), 6.17 (d, 1H, J 7.9), 5.66  (s, 2H, NH2), 2.21 (s, 3H, CH3).  Mp 232-234 oC. 
 
3.4 Synthesis of [PdCl(pyC6H4)(2-apym)] (4) - A solution of 2-apym (0.127 g, 1.337 mmol) 
in acetone (5 ml) was added to a yellow suspension of 1 (0.395 g, 0.668 mmol) in acetone (10 
ml). The yellow solution was stirred for 3 h, filtered and left to evaporate at room 
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temperature. The yellow cubic crystals formed were filtered off and dried under vacuum 
(0.390 g, 74 %). Anal. Calc. for C15H13ClN4Pd C: 46.1, H, 3.4, N, 14.3. Found: C, 46.0, H, 
3.4, N, 14.2 % IR (KBr) 3330s, 3170s, 3278s, 1649s, 1562s, 460s cm-1. 1H NMR (dmso-d6)  δ 
9.22 (d, 1H, J 4.0), 8.62 (d, 1H, J 4.0), 8.48 (s,1H), 8.20 (d, 1H, J 4.0), 8.04 (s, 2H, NH2), 
7.69 (d, 1H, J 4.0), 7.39 (s, 1H), 7.10 (d, 1H, J 8.0), 6.90 (d, 1H, J 8.0), 6.78 (d, 1H, J 4.0), 
6.53 (d, 1H, J 8.0), 6.20 (d, 1H, J 8.0). Mp 216-218 oC.  
3.5 Synthesis of [PdCl(pyC6H4)(2-etpy)] (5) - 2-Ethylpyridine (2-etpy) (0.280 g, 0.267 mmol) 
was added to a yellow suspension of 1 (0.0791 g, 0.1337 mmol) in EtOH (10 ml). The 
mixture was stirred for 3 h at room temperature. The yellow solution was filtered and allowed 
to evaporate at room temperature to give yellow cubic crystals (0.062 g, 63 %). Anal. Calc. 
for C18H17ClN2Pd, C, 53.5, H, 4.4, N, 7.1. Found: C, 53.4, H, 4.4, N, 7.1 % IR (KBr) 3056m, 
2962m, 1683w, 1604s, 406s cm-1. 1H NMR (dmso-d6) δ 9.47 (d, 1H, J 5.3), 8.80 (d, 2H, 6.3), 
7.81 (ddd, 1H, J 8.5, 8.0, 1.6), 7.65 (d, 1H, J 7.9), 7.47 (dd, 1H, J 7.7, 1.2), 7.29 (d, 2H, J 6.7), 
7.15 (ddd, 1H, J 7.2, 6.5, 1.6), 7.10 (ddd, 1H, J 7.5, 7.5, 1.2 ), 6.94 (ddd, 1H, J 7.6, 7.5, 1.6), 
6.25 (dd, 1H, J 7.7, 1.2), 2.76 (q, 2H, CH2, J 8.0), 1.32 (t, 3H, Me, 8.0). Mp 282 oC 
decomposed.  
3.6 Synthesis of [PdCl(pyC6H4)(2,6-dapy)] (6) - A solution of 2,6-dapy (0.024 g, 0.2219 
mmol) in EtOH (5 ml) was added to a suspension of 1 (0.065 g, 0.1109 mmol) in EtOH 
(10ml). The mixture was stirred for 4 h and the yellow solid formed was filtered and dried 
under vacuum. This was recrystallized from MeOH and benzene to give yellow 
microcrystalline solid (0.071 g, 88 %). Anal. Calc. for C16H15ClN4Pd, C, 47.4, H, 3.7, N, 
13.8. Found: C, 47.6, H, 3.5, N, 14.0 % IR (KBr) 3434-3402s, 3278s, 1602s, 487m cm-1. 1H 
NMR (dmso-d6)  δ 9.46 (d, 1H, J 3.9), 7.84 (ddd, 1H, J 7.8, 7.7,
 
1.6), 7.67 (d, 1H, J 7.9), 7.46 
(d, 1H, J 7.5), 7.34 (dd, 1H, J 7.9 , 4.0   ), 7.20 (ddd, 1H, J 7.2, 7.1, 1.2), 7.10 (ddd, 1H, J 7.6, 
7.5,
 
0.8), 6.95 (ddd, 1H, J 8.7, 7.6, 1.2), 6.32 (d, 1H, J 7.5), 6.04 (d, 2H, J 7.9), 5.44 (s, 4H, 
2NH2). Mp 254-256 C̊. 
3.7 Synthesis of [PdCl(pyC6H4)(2-acmpy)] (7) - Prepared and isolated by a method similar to 
that used for 2 except that NEt3 was not added. Yield, 61%. Anal. Calc. for 
C19H18ClN3OPdCl.0.25CH2Cl2, C, 49.4, H, 3.9, N, 8.9. Found: C, 49.4, H, 3.6, N, 8.2 % IR 
(KBr) 3211- 3168s, 2923w, 1683vs, 1602s, 1581m 405m cm-1. 1H NMR (dmso-d6), δ 9.74 
(s, 1H, NH), 9.35 (d, 1H, J 3.9), 8.65 (d, 1H, J 7.9), 7.84 (ddd, 1H, J 7.9), 7.79 (d, 1H, J 7.9), 
7.67 (d, 1H, J 7.9), 7.43 (d, 1H, J 7.9), 7.28 (ddd, 1H, J 7.9), 7.19 (ddd, 1H, J 5.9), 7.08 (ddd, 
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1H, J 7.9),  6.89 (ddd, 1H, J 7.9), 6.10 (d, 1H, J 7.9), 2.38 (s, 3H, MeCO), 2.23 (s, 3H, Me). 
Mp 310 C̊ decomposes. 
3.8 Synthesis of [PdCl(pyC6H4)(2-acpym)] (8) - A solution of 2-acpym (0.0184 g, 0.134 
mmol) in CH2Cl2 (5 ml) containing three drops of NEt3 was added to a yellow suspension of 
1 (0.0395 g, 0.067 mmol) in CH2Cl2 (10 ml). The yellow solution was stirred for 3 h, filtered 
and slow evaporation at room temperature gave a yellow precipitate which was recrystallized 
from CH2Cl2 and MeOH to give a yellow powder (0.041g, 71 %). Anal. Calc. for 
C17H15ClN4OPd, 47.1, H, 3.5, N, 12.9. Found: C, 47.3, H, 3.4, N, 13.2 % IR (KBr) 3330s, 
3170s, 3278s, 1649s, 1562s, 460s cm-1. 1H NMR (dmso-d6) δ 9.42 (d, 1H, J 4.0), 8.66 (d, 1H, 
J 4.0), 8.57 (s, 1H, NH), 8.47 (s, 1H), 7.84 (dd, 1H, J 7.9, 4.0), 7.67 (d, 1H, J 7.9), 7.47 (d, 
1H, J 7.9), 7.19 (dd, 1H, J 4.0, 4.0), 7.13 (dd, 1H, J 7.9, 4.0), 6.97 (dd, 1H, J 7.9, 3.8), 6.78 
(dd, 1H, J 4.0, 4.0), 6.31 (d, 1H, J 7.9), 1.63 (s, 3H). Mp 182-184 ºC. 
3.9 Synthesis of [PdCl(pyC6H4)(2-abzt)] (9) - A solution of 2-abzt (0.200 g, 1.337 mmol) in 
EtOH (5 ml) was added to a yellow suspension of 1 (0.395 g, 0.668 mmol) in EtOH (10 ml). 
The yellow solution was stirred for 2 h at room temperature, filtered and left to evaporate at 
room temperature. The yellow cubic crystals formed were filtered and dried under vacuum 
(0.480 g, 81 %). Anal. Calc. for C18H14N3SPdCl, C, 49.3, H, 3.9, N, 7.6. Found: C, 49.5, H, 
3.7, N, 7.8 % IR (KBr) 3255s, 3085s, 1614s, 1541s, 420m cm-1. 1H NMR (dmso-d6) δ 9.26 
(d, 1H, J 7.9), 8.02 (d, 1H, J 7.9), 7.99 (d, 1H, J 7.9), 7.67 (d, 1H, J 7.9), 7.62 (d, 1H, J 7.9), 
7.43 (s, 2H, NH2), 7.31-7.28 (m, 3H), 7.20-7.13 (m, 2H), 6.82 (dd, 1H, J 7.9, 1.2), 6.13 (d, 
1H, J 7.9). Mp 208-210 C̊.    
3.10 Synthesis of [PdCl(pyC6H4)(2-bzta)] (10) - A solution of 2-bzta (0.0513 g, 0.267 mmol) 
in CH2Cl2 (5 ml) was added to yellow suspension of 1 (0.0395 g, 0.0668 mmol) in CH2Cl2 
(10 ml). The yellow solution was stirred for 3 h, filtered and left to evaporate at room 
temperature. The yellow precipitate formed was recrystallized from CH2Cl2 and MeOH to 
give a yellow powder (0.078 g, 60 %). Anal. Calc. for C20H16ClN3OPdS.0.2CH2Cl2, C, 48.0, 
H, 3.2, N, 8.3. Found: C, 48.3, H, 3.2, N, 8.1 % IR (KBr) 3136-3109m, 3045m, 2958-2923m, 
1693s, 1602s, 1537vs, 437m cm-1. 1H NMR (dmso-d6) δ 10.99 (s, 1H, NH), 9.42 (s, 1H), 8.34 
(s, 1H), 7.88 (d, 1H, J 7.9), 7.82 (d, 1H, J 3.9), 7.70 (d, 1H, J 7.9), 7.45-7.37 (m, 3H), 7.23 
(dd, 1H, J 3.9, 2.0), 7.05 (dd, 1H, J 7.9, 4.0), 6.73 (dd, 1H, J 7.9, 3.0), 5.82 (s, 1H), 2.39 (s, 
3H, Me). Mp 264-266 ̊C. 
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3.11 Synthesis of [PdCl(pyC6H4)(κ1-dppmO)] (11) - A solution of dppmO (0.042 g, 0.10 
mmol) in CH2Cl2 (4 ml) was added to a suspension of 1 (0.036 g, 0.10 mmol) in CH2Cl2 (5 
ml). The mixture was heated under reflux for 2 h. The resulting yellow solution was filtered 
off and left to stand for slow evaporation for one day. The yellow solid formed was filtered 
off, dried and recrystallized from CH2Cl2/hexane to afford the product as yellow solid 
(0.0623 g, 82%). Anal. Calc. for C36H30NOP2PdCl: C, 62.1; H, 4.3; N, 2.0. Found: C, 61.9; 
H, 4.3; N, 2.1 %. IR (KBr): 3051m, 2950w, 1649m, 1562m, 1431s, 1261s, 1186s, 1101s, 
1018s, 800vs, 690m, 501m cm-1. 1H NMR (dmso-d6): δ 9.27 (s, 1H), 8.16 (s,1H), 7.92-7.35 
(m, 22H), 7.17 (d, 1H), 6.97 (t, 1H, J 8.0), 6.51 (t, 1H, J 7.5), 6.29 (t, 1H, J 7.6), 4.39 (t, 2H, J 
12.0, CH2). 31P NMR (dmso-d6): δ 32.6 (vbrs, Ph2PO), 28.3 (s, Ph2P) ppm. Mp 162-164 oC. 
3.12 Synthesis of [PdCl(pyC6H4)(κ1-dppeO)] (12) - This complex was prepared and isolated 
in a similar manner that used for 11 to afford 13 in 68% yield. Anal. Calc. for 
C37H32NOP2PdCl: C, 62.6; H, 4.5; N, 2.0. Found: C, 62.5; H, 2.5; N, 2.0 %. IR (KBr): 
3055m, 2916m, 2850w, 1731m, 1596m, 1566m, 1481m, 1434s, 1186vs, 1114m, 1016m, 
730m, 692m, 513m, cm-1. 1H NMR (dmso-d6): δ 9.45 (s, 1H), 8.12 (d, 1H, J 8.0), 7.91(d, 1H, 
J 7.4), 7.89(d, 1H, J 7.4), 7.75 (d, 1H, J 7.6), 7.61-7.45 (m, 20H), 6.96 (t, 1H, 7.9), 6.51 (t, 
1H, J 7.9), 6.44 (t,1H, J 7.8), 2.59 (m, 4H, 2CH2) ppm. 31P NMR (dmso-d6): δ 38.9 (d, J 52, 
Ph2PO), 30.3 (d, J 52, Ph2P) ppm. Mp 212-216 oC.  
3.13 Synthesis of [Pd(pyC6H4)(κ2-dppmO)]NO3 (13) - A solution (5 ml) of silver nitrate 
AgNO3 (0.052 g, 0.05 mmol) in a mixture of EtOH/H2O (1:2) was added to a solution of 11 
(0.041 g, 0.05 mmol) in CH2Cl2 (4 ml). The mixture was stirred in dark for 2 h, the mixture 
was filtered off to remove solid AgCl and the mother liquor was left for slow evaporation at 
room temperature to afford a yellow solid. This was filtered off, washed with water, dried and 
recrystallized from CH2Cl2 (0.0482 g, 88%). Anal. Calc. For C36H30N2O4P2Pd: C, 59.8; H, 
4.2; N, 3.9. Found: C, 59.6; H, 4.0; N, 3.3 %. IR (KBr): 3055m, 2923m, 1625m, 1558m, 
1485w, 1436m, 1382s, 1132m, 740m, 692m, 509m  cm-1. 1H NMR (dmso-d6): δ 9.06 (s, 1H), 
8.25 (d, 1H, J 7.0), 7.86-7.44 (m, 22H), 7.07 (t, 1H, J 7.5), 6.63 (t, 1H, J 7.5), 6.38 (t, 1H, J 
7.5), 4.59 (t, 2H, J 8.0, CH2) ppm.  31P NMR (dmso-d6): δ 54.3 (d, J 53, Ph2PO), 28.2 (d, J 53, 
Ph2P) ppm. Mp 154-156 oC. 
3.14 Synthesis of [Pd(pyC6H4)(κ2-dppeO)]NO3  (14) - This complex was prepared and 
isolated in a manner similar to that used for 13 to afford 14 in 92% yield. Anal. Calc. for  
C37H32N2O4P2Pd: C, 60.2; H, 4.5; N, 3.8. Found: C, 60.4; H, 4.3 ; N, 3.7 %. IR (KBr): 
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3058w, 2920w, 1652m, 1600m, 1560m, 1481m, 1434m, 1380s, 1126m, 730s, 694s, 545m, 
507m cm-1. 1H NMR (dmso-d6): δ 8.95 (s, 1H), 8.25 (s, 1H), 7.93-7.47 (m, 22H), 7.03 (t, 1H, 
J 6.6), 6.96 (t, 1H, J 7.5), 6.38 (t, 1H, J 7.6), 2.83-2.75 (m, 4H, 2CH2) ppm. 31P NMR (dmso-
d6):  δ 46.4 (brs, Ph2PO), 36.2 (brs, Ph2P) ppm.  Mp: 153-155 oC. 
3.15 Crystallography 
Single crystals of 2 and 3 were mounted on glass fibres and all geometric and intensity data 
were taken from these samples using a Bruker SMART APEX CCD diffractometer using 
graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å) at 150 ± 2 K. Data collection, 
indexing and initial cell refinements were all done using SMART software. Data reduction 
were carried out with SAINT PLUS and absorption corrections applied using the programme 
SADABS [44]. Structures were solved by direct methods or Patterson methods and 
developed using alternating cycles of least-squares refinement and difference-Fourier 
synthesis. All non-hydrogen atoms were refined anisotropically. Hydrogens were placed in 
calculated positions (riding model). Structure solution used SHELXTL PLUS V6.10 program 
package [45]. 
Single crystals of 4 and 9 were mounted on a SuperNova, Dual Atlas diffractometer using a 
Nylon Loop. The crystals were kept at 150(1) K during data collection. Using Olex2 [46] the 
structure was solved using Direct Methods. The structures were refined with the ShelXL 
refinement package using Least Squares minimization [47]. All non-hydrogen atoms were 
refined anisotropically and hydrogen atoms (except those directly bonded to metals) were 
included using a riding model.  
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Table 1. Crystallographic data 
Compound 2 3 4 9 
Empirical formula 
Formula weight (Å) 
Temperature (K)                      
Wavelength (Å) 
Crystal system                          
Space group  
Unit cell dimensions                
a (Å)                          
b (Å)                                         
c (Å)                                         
α (°)                                          
β (°)  
γ (°)                                           
Volume (Å3)                      
Z    
Density (calculated) (Mg/m3) 
Absorption coefficient (mm-1) 
F(000)                                    
Crystal size (mm)                  
θ Range for data collection (°) 
 Index ranges 
 
  
Reflections collected 
Independent reflections [Rint] 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2σ(I)] 
 
R indices (all data) 
 
Largest diff. peak and 
hole(e.Å-3) 
C16H14ClN3Pd 
390.15 
)2(150  
0.71073 
monoclinic 
P21/c  
 
11.345(3) 
7.112(2)  
17.798(5)  
90 
96.626(4) 
90 
1426.5(7) 
4 
1.817 
1.483 
776 
0.42 × 0.38 × 0.22 
2.76 to 28.36 
−14 ≤ h ≥ 14 
−9 ≤ k ≥ 9 
−23 ≤ l ≥ 23 
10871 
3253 [Rint = 0.0299] 
3253 / 0 / 246 
0.969  
 R1 = 0.0252, 
 wR2 = 0.0598 
R1 = 0.0328,  
wR2 = 0.0612 
0.473 and -0.469 
C17H16ClN3Pd 
404.18 
)2(150  
0.71073 
monoclinic 
P21/n  
 
12.171(5) 
7.602(3)  
16.554(7)  
90 
99.010(6) 
90 
1512.7(11) 
4 
1.775 
1.402 
808 
0.28 × 0.26 × 0.08 
2.25 to 28.10 
−15 ≤ h ≥ 16 
−9 ≤ k ≥ 9 
−21 ≤ l ≥ 21 
11390 
3402 [Rint = 0.0436] 
3402 / 0 / 199 
0.944  
 R1 = 0.0363, 
 wR2 = 0.0832 
R1 = 0.0513,  
wR2 = 0.0857 
1.301 and -1.301 
C15H13ClN4Pd 
391.17  
)2 (150  
0.71073  
monoclinic  
P21/c  
 
9.1845(4) 
9.2070(3)  
17.6564(7)  
90 
104.926(5) 
90 
1442.67(3) 
4 
1.8008 
1.469 
772.8 
0.33 × 0.17 × 0.09 
6.38 to 59.1 
−12 ≤ h ≥ 12 
−12 ≤ k ≥9 
−24 ≤ l ≥ 23 
9885 
3529 [Rint = 0.0445] 
3529 / 0 /189 
1.039  
 R1 = 0.0306, 
 wR2 = 0.0731 
R1 = 0.0334,  
wR2 = 0.0757 
1.07 and -0.86 
C54H42Cl3N9Pd3S3 
1338.80  
)2 (150  
0.71073  
monoclinic  
P21/n  
 
7.1075(2) 
32.6357(9)  
22.3095(7)  
90 
90.270(3) 
90 
5174.8(3) 
4 
1.7183 
1.356 
2656.1 
0.39 × 0.29 × 0.08 
5.62 to 59.2 
−9 ≤ h ≥ 7 
−37 ≤ k ≥41 
−30 ≤ l ≥ 21 
40206 
12564 [Rint = 0.0424] 
12564 / 0 / 648 
1.058  
 R1 = 0.0403, 
 wR2 = 0.0795 
R1 = 0.0498,  
wR2 = 0.0847 
1.20 and -0.99 
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Table 2. Selected bond lengths (Å) and angles (º) 
2 
Pd(1)–N(1) 2.0140(19) Pd(1)–Cl(1) 2.4042(8) 
Pd(1)–N(2) 2.025(2) Pd(1)–C(11) 1.954(2) 
N(1)–Pd(1)–Cl(1) 96.40(6) N(2)–Pd(1)–Cl(1) 91.16(6) 
N(1)–Pd(1)–N(2) 170.09(8) C(11)–Pd(1)–N(1) 81.37(9) 
C(11)–Pd(1)–N(2) 91.36(9) C(11)–Pd(1)–Cl(1) 176.54(7) 
3 
Pd(1)–N(1) 2.009(3) Pd(1)–Cl(1) 2.3697(11) 
Pd(1)–N(2) 1.999(3) Pd(1)–C(17) 1.951(3) 
N(1)–Pd(1)–Cl(1) 88.96(9) N(2)–Pd(1)–Cl(1) 95.71(9) 
N(1)–Pd(1)–N(2) 175.31(11) C(17)–Pd(1)–N(2) 81.88(13) 
C(17)–Pd(1)–N(1) 93.43(13) C(17)–Pd(1)–Cl(1) 176.07(10) 
4 
Pd(1)–N(1) 2.0309(19) Pd(1)–C(1) 1.987(2) 
Pd(1)–N(2) 2.0453(19) Pd(1)–Cl(1) 2.4200(6) 
N(1)–Pd(1)–Cl(1) 95.76(6) N(2)–Pd(1)–Cl(1) 90.02(6) 
N(1)–Pd(1)–N(2) 171.46(8) C(1)–Pd(1)–Cl(1) 175.95(7) 
C(1)–Pd(1)–N(1) 81.26(9) C(1)–Pd(1)–N(2) 93.25(9) 
9 
Pd(1)–N(1) 2.032(2) Pd(1)–C(1) 1.982(3) 
Pd(1)–N(2) 2.029(2) Pd(1)–Cl(1) 2.4251(7) 
N(1)–Pd(1)–Cl(1) 97.90(7) N(2)–Pd(1)–Cl(1) 88.37(7) 
N(1)–Pd(1)–N(2) 171.83(9) C(1)–Pd(1)–Cl(1) 172.54(8) 
C(1)–Pd(1)–N(1) 81.26(11) C(1)–Pd(1)–N(2) 93.20(11) 
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    (a)       
   (b)   
Figure 1. The molecular structures of (a) [PdCl(pyC6H4)(2-apy)] (2) and (b) 
[PdCl(pyC6H4)(2-apym)] (4)  
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Figure 2. Two views of the molecular structure of [PdCl(pyC6H4)(2-ampy)] (3)  
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Figure 3. The molecular structure of one independent molecule of [PdCl(pyC6H4)(2-abzt)] 
(9)  
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Highlights 
 
• Synthesis of cyclometalated palladium(II) complexes [PdCl(pyC6H4)(L)] 
• Crystal structure of four examples 
• Synthesis of chelate complexes [Pd(pyC6H4)(κ2-diphospineO)]Cl 
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Graphic 
 
              
Graphic abstract 
 
Cyclometalated palladium(II) complexes, [PdCl(pyC6H4)(L)], containing amino-pyridine, 
acetylamino-pyridine or diphosphine monoxide co-ligands (L) have been prepared and crystal 
structures of four examples are reported, each showing a distorted square planer geometry 
around palladium with the N-coordinated amino- or acetylamino-pyridine ligand lying almost 
perpendicular to the square-plane. Removal of the chloride from the diphosphine monoxide 
complexes upon addition of AgNO3 lead to the formation of [Pd(pyC6H4)(κ2-dppmO)][NO3] 
and [Pd(pyC6H4)(κ2-dppeO)][NO3] in which the ligands are believed to bind in a chelate 
fashion. 
 
